1. Home
  2. Analysis
  3. Pentoxifylline
  4. Constipation

Pentoxifylline and Constipation - a phase IV clinical study of FDA data

Summary:

Constipation is reported as a side effect among people who take Pentoxifylline (pentoxifylline), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Vitamin D3, and have Pain.

The phase IV clinical study analyzes which people have Constipation when taking Pentoxifylline. It is created by eHealthMe based on reports of 5,929 people who have side effects when taking Pentoxifylline from the FDA, and is updated regularly.

What is Pentoxifylline?

Pentoxifylline has active ingredients of pentoxifylline. eHealthMe is studying from 5,997 Pentoxifylline users. Check the latest studies of Pentoxifylline.

What is Constipation?

Constipation is found to be associated with 3,004 drugs and 4,616 conditions by eHealthMe. Check the latest studies of Constipation.

On Aug, 06, 2026

5,929 people reported to have side effects when taking Pentoxifylline.
Among them, 69 people (1.16%) have Constipation.

Could Pentoxifylline cause Constipation?

Among these 69 people:

How long have people been on Pentoxifylline when they have Constipation? *

  • < 1 month: 100 %
  • 1 - 6 months: 0.0 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

What is the gender of people who have Constipation when taking Pentoxifylline? *

  • female: 53.85 %
  • male: 46.15 %

What is the age of people who have Constipation when taking Pentoxifylline? *

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 1.72 %
  • 50-59: 22.41 %
  • 60+: 75.86 %

What are other drugs people take besides Pentoxifylline? *

  1. Vitamin D3: 11 people, 15.94%
  2. Hydroxyzine: 8 people, 11.59%
  3. Morphine: 8 people, 11.59%
  4. Lorazepam: 8 people, 11.59%
  5. Sertraline: 7 people, 10.14%
  6. Oxycodone: 7 people, 10.14%
  7. Aspirin: 7 people, 10.14%
  8. Lasix: 7 people, 10.14%
  9. Torecan: 6 people, 8.70%
  10. Plavix: 6 people, 8.70%

What are other side effects people have besides Constipation? *

  1. Weakness: 19 people, 27.54%
  2. Nausea (feeling of having an urge to vomit): 13 people, 18.84%
  3. Fatigue (feeling of tiredness): 13 people, 18.84%
  4. Pain: 12 people, 17.39%
  5. Abdominal Pain: 12 people, 17.39%
  6. Diarrhea: 11 people, 15.94%
  7. Drug Ineffective: 10 people, 14.49%
  8. Chest Pain: 10 people, 14.49%
  9. Nausea And Vomiting: 10 people, 14.49%
  10. Dizziness: 9 people, 13.04%

What are the existing conditions these people have? *

  1. Pain: 14 people, 20.29%
  2. Peripheral Vascular Disorder: 7 people, 10.14%
  3. High Blood Pressure: 7 people, 10.14%
  4. Muscle Aches (muscle pain): 6 people, 8.70%
  5. Back Pain: 5 people, 7.25%
  6. Quit Smoking: 5 people, 7.25%
  7. Multiple Myeloma (cancer of the plasma cells): 4 people, 5.80%
  8. Heart Disease: 4 people, 5.80%
  9. Hyperkalemia (damage to or disease of the kidney): 3 people, 4.35%
  10. Prostate Cancer: 3 people, 4.35%

* Approximation only. Some reports may have incomplete information.

Do you take Pentoxifylline and have Constipation?

- Check whether Constipation is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Pentoxifylline:

Constipation treatments and more:

How severe was Constipation and when was it recovered:

Expand to all the drugs that have ingredients of pentoxifylline:

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Pentoxifylline:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Constipation:

Browse all the conditions that are associated with Constipation:

How the study uses the data?

The study uses data from the FDA. It is based on pentoxifylline (the active ingredients of Pentoxifylline) and Pentoxifylline (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.